Lorcaserin shows cardiovascular safety
Aug 27, 2018•7 min•Season 1Ep. 145
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Lorcaserin is the first weight-loss drug proven to have cardiovascular safety. Also today, live attenuated flu vaccine gets the nod for upcoming flu season, PCSK9 inhibition helps patients with metabolic syndrome, and breastfeeding may reduce the risk of stroke decades later. Subscribe to the MDedge Daily News wherever you get your podcasts.
For the best experience, listen in Metacast app for iOS or Android
Open in Metacast